Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Barley beta-glucan (Barliv barley betafiber): Pre-diabetes - Nutraceuticals World
Research

Barley beta-glucan (Barliv barley betafiber): Pre-diabetes

Nutraceutical: Barley beta-glucan (Barliv barley betafiber)
 
Indication: Pre-diabetes
 
Source: Nutr Metab, August 16, 2011;8(1):58.
 
Research: This 12-week randomized, placebo-controlled, double-blind, clinical trial assessed the impact of barley beta-glucan (Barliv barley betafiber) on glucose levels and insulin sensitivity. Because weight changes can impact both of these variables, researchers took steps to ensure that the 50 healthy participants—each at risk for type 2 diabetes mellitus—kept their weight constant during the trial period. Participants consumed three low-dose (3 grams Barliv barley betafiber/day) or high-dose (6 grams Barliv barley betafiber/day) 11-ounce test beverages each day with their meals.
 
Results: The findings suggest that 6 grams/day of Barliv barley betafiber over 12 weeks can improve insulin sensitivity among generally healthy people with pre-diabetes, who have no prior diagnosis of diabetes mellitus and no change in body weight.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters